ABOS
Acumen Pharmaceuticals Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $3.9
- Day High
- $3.96
- Day Low
- $3.8
- Day Open
- $3.84
- Volume
- 6195
- Day Change
- 3.33%
Latest news data for ABOS
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2022 Financial Results on March 27, 2023
globenewswire.com
Acumen Pharmaceuticals to Participate in the Needham Neuroscience Forum
globenewswire.com
BMEZ CEF: Significant Risks Remain (NYSE:BMEZ)
seekingalpha.com
Acumen Pharmaceuticals: An Alzheimer's 'Lottery Ticket' (NASDAQ:ABOS)
seekingalpha.com
Acumen Pharmaceuticals, Inc. (ABOS) CEO Daniel O'Connell on Q3 2022 Results - Earnings Call Transcript
seekingalpha.com
Acumen Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:ABOS)
seekingalpha.com
Acumen Publishes Phase 1 Trial Design and Clinical Development Plan for ACU193, an Anti-Amyloid Beta Oligomer Antibody for Alzheimer's Disease
marketscreener.com
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Update
etfdailynews.com
Acumen Pharmaceuticals Shares Rise After FDA Designation
marketscreener.com
These Are the Five Best and Worst Performing Small-cap Stocks in September 2022 – 24/7 Wall St.
247wallst.com